Approximately every three seconds a person somewhere in the world is diagnosed with a chronic progressive neurological syndrome associated with dementia The number of people with dementia is doubling every 20 years, in part owing to ageing of the population, and by 2050 is predicted to reach an estimated 152 million people 1 (Fig. 1) . Much of this growth in dementia will continue to be in developing countries and, in particular, countries with a rapid increase in the ageing population, such as China and India 1 . These statistics are fairly new in the span of human history; even as recently as the 1900s, individuals in Western countries rarely lived into their 90s, whereas today the largest growth in the population is in individuals aged 80 years or over 3 . As a result, age-related conditions such as AD are increasing in prevalence. The initial symptoms of AD are losses in short-term memory, which are followed by declines in long-term memory, language, problemsolving and other cognitive functions. Affected individuals initially require fear and hopelessness continues to influence the care offered to people with dementia in Western countries. In other countries, by contrast, dementia is accepted as a normal condition of ageing, and affected people are encouraged to engage and remain in their community 7 . Such cultural variations contribute to large geographical discrepancies in dementia treatment and care.
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. Alzheimer disease (AD) is the most common cause of dementia. Currently, around 50 million people are living with dementia worldwide 2 .
The number of people with dementia is doubling every 20 years, in part owing to ageing of the population, and by 2050 is predicted to reach an estimated 152 million people 1 ( Fig. 1) . Much of this growth in dementia will continue to be in developing countries and, in particular, countries with a rapid increase in the ageing population, such as China and India 1 . These statistics are fairly new in the span of human history; even as recently as the 1900s, individuals in Western countries rarely lived into their 90s, whereas today the largest growth in the population is in individuals aged 80 years or over 3 . As a result, age-related conditions such as AD are increasing in prevalence. The initial symptoms of AD are losses in short-term memory, which are followed by declines in long-term memory, language, problemsolving and other cognitive functions. Affected individuals initially require fear and hopelessness continues to influence the care offered to people with dementia in Western countries. In other countries, by contrast, dementia is accepted as a normal condition of ageing, and affected people are encouraged to engage and remain in their community 7 . Such cultural variations contribute to large geographical discrepancies in dementia treatment and care.
It is important to consider what types of care should be offered to people with dementia in the future. Other key questions are who will care for this population and what will that care look like? Will dementia continue to be seen as a hopeless diagnosis, or will it be viewed more positively as a condition in which people know they have a future as part of a society that understands their needs and can care for those needs? Will people with dementia continue to be placed in nursing homes once the required level of community care cannot be provided, or will they enter end-of-life or palliative care settings only to live out their final weeks or days? In the context of an ageing population, we must also wonder whether there will be enough younger, healthy people to provide this care. In super-aged countries, such as Japan, there are already not enough young people to provide care for their ageing population. Japan has responded to this lack of young workers by pushing forward with the development of technologies to assist with care provision.
A US national consensus panel convened by the Johns Hopkins Translational Aging Services Core recommends home-based care for people with dementia as the nexus of economically efficient long-term care models, and the preference is for people with dementia to stay in their own home as long as possible 8 . Accordingly, in this Perspectives article, I discuss several areas highlighted by the Johns Hopkins panel in which technology can support home-based care for people living with dementia 8 : assessment and monitoring technologies, assistive devices, therapeutic devices and caregiversupportive technologies. Unfortunately, the effectiveness of these technologies is complicated by the stage and speed of development. Some technologies are in the ascent phase, where research costs assistance with tasks related to memory and navigation; as the syndrome progresses, they require increasing levels of support for all activities of daily living.
In the past, people with dementia were often banished to so-called lunatic asylums 4 . However, once it was understood that people with dementia had a medical condition that was destroying their brains, they were accepted into nursing homes, where they often would arrive early in the trajectory of their condition and live many years locked away from society. Today, increased understanding of the importance of personhood has helped people with dementia to remain as long as possible in their own community, where family and friends, alongside community support services, manage the person's daily needs. Despite these improvements in care, however, people with dementia often continue to feel stigmatized by a society that often does not understand what it is to have a diagnosis of dementia or what such a condition means to the person, their family, and friends 5, 6 . Being treated as an 'outsider' or person of little importance encourages a sense of being an outcast of society. Perhaps because dementia has no cure, this sense of
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have been recovered and the technology is entering evidence-based practice, whereas other products are early in development. Not all products are fit for purpose, and few are affordable or widely available. Here, I discuss the challenges facing integration of technologies into dementia care and suggest guidelines for their development and implementation. It is imperative that we build a future alongside smart assistive technology and robotics to augment human care provision and thereby transform dementia services and support. There is little doubt that the future will hold a stronger place for these technologies.
The technologies
Current technologies have focused on helping people who are in the early stages of their syndrome to remain independent, improving social participation, security and monitoring of physical and behavioural status (Table 1) . These technologies could help to fill a gap in care support if they can help to maintain a person comfortably in their community and promote independence, positive mood and quality of life for the person living with dementia, as well as supporting the family carer. However, future dementia care demands technology that can also reduce stigmatization and discrimination towards people with dementia. To date, no technologies have been developed that achieve this.
Assessment and monitoring. The past few years have seen a large increase in the demand for smart home technology, such as Google Home, which reminds us of the date, tells us what the weather will be like tomorrow and takes control of our home lighting, heating and oven from a smart phone. Such technologies are non-intrusive (in that they do not require ongoing assistance from human interaction), are useful for society at large and can help people with dementia, especially those early in their disease course, to remain independent.
Older people with dementia living alone in the community face risks to their safety, health and psychological wellbeing. Advances in artificial intelligence (AI), including the internet of Things (IoT), can help individuals to remain independent. Wearable devices connected via the IoT enable carers and health professionals to monitor an individual's environment, health and well-being in real time. Such systems learn the physical habits and symptoms of the person and can raise concern before the occurrence of adverse events, such as a fall or severe illness. However, effective predictive models require a personalized approach to monitoring and, therefore, can be an expensive option.
Older people with dementia living alone often face loneliness and social isolation 9 . Installation of sensors in the home can provide an effective means of monitoring well-being, physical activity and social participation. For example, sensors can detect behaviours, such as time spent in particular rooms in the house, time spent lying prone, daytime and night-time sleep and time spent out of the home. These sensors can alert carers or emergency services if they detect any potential problems. Such information can help to detect individuals who are at risk of social isolation or of wandering 10 so that appropriate care programmes can be put into place that enable people with dementia to stay in the community for longer.
Assistive robotic technologies.
Assistive technology can help people remain independent and provide relatives with reassurance. Over the past decade, researchers have reported that professional caregivers and older people are curious about and open to the use of robots in care 11, 12 . Assistive robots can provide physical care and social support. They can also provide reminders about appointments, medications and dietary requirements and can alert individuals to the risk of a fall or dehydration. Importantly, they do not arrive with any 'social baggage' , which can impede care, and they do not judge people.
One such robot is RAMCIP (Robotic Assistant for mild cognitive impairment (MCI) Patients at home), a service robot developed through a recently completed European Union (EU) 2020 Horizon Project 13 . The eight research partners from six countries used a collaborative design process to identify the requirements for a robot intended to assist older people with MCI to stay in their own homes. This process incorporated focus groups and surveys of medical staff (n = 100), caregivers (n = 81) and potential end users (n = 83) 14 . RAMCIP performs tasks such as detecting falls, turning on lights, monitoring individuals, bringing medications and water, picking up objects and connecting the person to their family via a videoconferencing system. To date, pilot trials of RAMCIP have been conducted in the homes of ten users 15 . Another example is Care-O-Bot, a mobile assistant developed at the Fraunhofer Institute for Manufacturing Engineering and Automation, Germany. Care-O-Bot was built to support people in various activities of daily living.
Glossary
Artificial intelligence (ai) . an area of computer science that emphasizes the creation of machines that function and respond similarly to humans. Computerized ai systems have been designed for speech recognition, machine learning, planning and problem-solving.
Internet of Things
(ioT). The interconnection of computing devices embedded in everyday objects, which enables them to send and receive data over the internet.
Social baggage
a metaphor that represents our experiences and memories that we bring with us from our past.
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. robots need to be sufficiently advanced to undertake multiple tasks within the home environment to avoid the need for purchase and use of multiple technologies 19 . One of the greatest challenges faced by people after receiving a diagnosis of dementia is the loss of independence associated with cancellation of their driver's licence due to cognitive impairment. The future holds opportunities to maintain these individuals' independence through the introduction of self-driving cars. Although considerable scepticism persists about the safety of such cars, the evidence is going some way towards alleviating those fears 20, 21 . A future exists in which people with dementia will be able to call for an autonomous car to take them to their clinic appointments, supermarket, family and friends, all without fear of getting lost or causing an accident.
However, although a number of apparently promising assistive and robotic technologies are being developed, such products often do not reach the market for which they are intended, and only a limited number become commercially available 22 . Reasons for this situation might be related to their development in universities or research institutes, which do not necessarily seek opportunities for commercialization of their products, and to the feasibility of the technology to accomplish the tasks assigned. In some cases, developers have paid only limited attention to the needs of end users from conceptualization of the product through to testing and commercialization 23 . Finally, the lengthy time necessary for development of sophisticated robots generates high production costs and increases the risk that competing technologies might be launched before the original product can be commercialized 24, 25 . Therapeutic technologies. Several different versions of therapeutic robots have been designed to support individuals with dementia. Telepresence robots, for example, are remotely controlled mobile videoconference systems that can improve social participation through video-conferencing with family and friends anywhere in the world. Other robotic systems can provide stimulating entertainment, and virtual reality can stimulate new experiences and reduce apathy 26, 27 . Other robots include cute and cuddly therapeutic pet-type robots, such as PARO, which was developed in Japan and modelled on a baby harp seal 28 . Such robots encourage engagement and social connection without the support needs of a real animal. Varying levels of evidence support the utility of each of these devices, with PARO having the best evidence available for reducing the behavioural and psychological symptoms of dementia [28] [29] [30] .
Caregiver support. An increasing number of applications are being developed to assist and support caregivers. Applications used with smart photo albums or tablets can be used for reminiscence therapy 31 . These are currently some of the most useful supportive devices.
In addition, lifting robots such as RIBA II can enable patients up to 80 kg in weight to be safely transferred from the floor or bed into a chair or wheelchair 32 . Assistive devices, such as the Obi robotic spoon, enable people with limited mobility to feed themselves without spilling food. These technologies help individuals to remain independent and reduce the burden on carers.
Obstacles and challenges
Despite the surge in technological development over the past decade, societal views about the acceptability of robots can be a barrier to their use. Acceptance might be dependent on whether robots are seen as technology that works alongside or as a supplement to carers or as a replacement for human employees [33] [34] [35] . Although some members of society might imagine a future where care workers will all be robots 36 , such a future will not occur as long as humans value the importance of human life and caregiving. Care for people with dementia is complex and demands a flexible approach suited to the person's physical and cognitive needs. It would take an incredibly sophisticated AI system to predict and respond to all their personal care needs appropriately. I imagine a future situation in which robots will help with particular tasks and offer a substitute for human care during those inevitable times when human assistance is not available.
Robots potentially have many advantages compared with human care. They can be programmed to provide care in an emotionally supportive way that avoids abuse of the rights of the person. Human care can be less consistent, and the quality of human-provided care depends on how busy the carer is and how they feel about the individual. Such factors, in the worstcase scenario, can result in the abuse of patients by their carers. However, ethical arguments continue to be made against the use of technology in care and in particular against the use of robots. For example, some individuals have argued that robots should not provide care unless they can give the impression of emotional engagement with care recipients 37 . Despite advances in this area, the majority of available technologies do not appropriately recognize or react to human emotions 38 . Debate is ongoing worldwide as to whether robots will be good or bad for society. In 2015, a survey of public attitudes towards robots found that, overall, EU citizens presented positive attitudes about robots and were willing to have robots assist them in their work 39 . Interestingly, these survey respondents showed widespread agreement (60%) that robots should not care for children, older people or disabled persons. However, governmental policy groups are moving forward with different recommendations, which suggests that these groups have not been speaking to each other. For example, the European Commission ICT-AGE research project, which aimed to develop guidelines for member states on how to design long-term care strategies to help older people to live independently, recommended in their 2015 report that assistive robots and social robots should be included in technology-enabled services as a means to help older people live at home independently 40 . Furthermore, the European Commission continues to support opportunities to develop AI systems and robots to improve the care of older people 41, 42 . Despite these advances, ethical issues remain prominent in the literature, with the argument being that these technologies might deceive patients and take away the dignity of care [43] [44] [45] . For example, a person with dementia might perceive a robotic animal to be a 'real' animal. These dilemmas remain to be addressed and, in addition to the high cost of the products, might also contribute to the slow adoption of robotic and assistive technologies in dementia care 38 . However, with changing attitudes to technology and ongoing technical development, the ethical issue in the future might become 'why can't I have such technologies?' rather than 'should we introduce these technologies?' .
Humanoid robots might find increased acceptance, as these robots look human-like and interact naturally with people. However, concerns arise, such as who is responsible for repairs if the robot breaks down, and a worldwide service contract has not been 46 . In Japan, owners are often so attached to their robotic dogs that unrepairable ones are given funerals as a way of saying goodbye 47 . Importantly, the legal implications of technologies that collect, store and upload health data have not been widely considered. Unless privacy and security are addressed, these devices place users at risk of their information being widely disseminated. Furthermore, a growing number of countries require technologies to be approved for specific medical indications by regulatory bodies such as the FDA, the Australian Therapeutic Goods Administration and the European Commission. These bodies aim to ensure the safety and effectiveness of technologies used as medical devices or involving the diagnosis, prevention, monitoring, treatment or alleviation of disease. However, the process of approval is so complex that some medical device developers believe it impedes innovation and delays the availability of new technology, and they advocate that this approval process needs to be simplified 48, 49 . The robots discussed in this Perspectives article are considered to be medical devices because they are intended to be used in the treatment of dementia, such as for reducing its behavioural and psychological symptoms or assisting with functional disability or communication. However, only PARO has gone through the complex process of gaining regulatory approval.
To date, although these technologies are used in several countries, they are not used globally in dementia care. A key issue is related to the limited end-user engagement in their design and development; as a result, the technologies are frequently seen as being unfit for purpose by carers, patients and health-care providers 50 . Furthermore, most potential users remain ignorant of the availability of these technologies. The high cost of some devices places them beyond the reach of most members of society, although PARO achieved medical device status in the USA in 2009, which enables clients to be reimbursed through Medicare and some private insurance companies for prescribed therapy with PARO 51 . Furthermore, in Australia, elderly patients have been able to purchase PARO through the government-funded Home Care Packages programme 52 . Such schemes have enabled patients to access assistive technologies regardless of their financial circumstances.
Finally, carers require training in how and when to use the technology, how to obtain technological support and how to monitor and assess its use. Home environments might also need to be adapted to facilitate the use of technologies (in particular, storage of large robotic platforms).
Guidelines box 1 outlines key criteria that should guide technological development and that are based on empirical evidence and expert opinion. The development of technologies that will be useful for end users requires their engagement at all levels of design and implementation, not just a short trial once the device has been created. Such involvement ensures that end users' needs and concerns are adequately addressed.
Notably, governments need to show that they value innovation and support sophisticated but high-risk initiatives that have the potential to improve future dementia care. Universities need to move beyond research and aim for the commercialization of products that have been shown to be useful. Once products become commercially available, their cost will reduce as greater numbers of people purchase the products. Importantly, new technologies must be able to undertake a multitude of tasks, particularly those related to self-care, and must deliver those tasks according to the user's preferences 22, 53 . Robots must also be able to react in an acceptable manner to human emotions. Finally, societal views on monitoring and privacy must be carefully considered to obtain the full benefit of these devices in the care of older people with cognitive impairment. Required criteria • Technologies must be based on a theoretical framework that shapes the technological innovation • The development team must include experts in dementia as well as end users such as carers, patients, developers and health-care professionals • Products must be conceptualized and developed with input from end users at all stages • Devices must be trialled and tested by end users and adapted to their needs • Technology must be capable of multiple tasks to enable sustainability across the stages of dementia • Technology must be well tested and beyond the early prototype stage for commercialization to be considered • Technology must adhere to privacy standards for the collection, use, storage and transmission of patient data • Pricing of the technology must consider not only research, development and production costs but also a viable purchase cost for the intended market • Robots must be developed that react appropriately to human emotions • Technologies must be easily incorporated into the Internet of Things • Technological support must be developed and delivered using multiple platforms (such as telephone helplines, online videos and printed problem-solving information) • Research exploring the effectiveness of the technology must move from small descriptive studies to incorporate larger randomized controlled trials • Research must include the cost-effectiveness of technology Criteria supporting technology development • Governments must value innovation and support technology development • universities and research institutes must promote the commercialization of products they have developed • medical device regulation bodies must aid developers to gain approval for devices • Potential adverse effects of the technology must be reported • National and international organizations focusing on Alzheimer disease and other causes of dementia should provide detailed information a on available technologies a Including, for example, case studies, examples of use, cost and where they can be purchased.
Conclusions
This Perspectives article addresses the contribution of technologies to the future of dementia care. As the number of people with dementia is expected to continue to grow well into the future, it is likely that we will reach a stage where we have little choice but to integrate technology alongside humanprovided care in order to manage the needs of people living with dementia. Although ethical challenges continue to raise concerns, we must learn to think of technology as part of our society if we are to broaden the opportunities for home-based care of people with dementia. The main focus of the groups producing these technologies should be on involving both people with dementia and their carers in the design of ethical products that meet end-user needs. Such technologies offer great promise for assisting with the physical and cognitive challenges of people with dementia and in helping to reduce the burden on carers and the challenges of an ageing workforce.
